Global Viral Sensitizers Market Research Report 2023-2035: Development of Gene Therapy Breakthroughs and Surging Demand for Vaccines Emerge as Key Drivers [Yahoo! Finance]
Arrowhead Pharmaceuticals, Inc. (ARWR)
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arrowheadpharma.com/investor-relations
Company Research
Source: Yahoo! Finance
Area (Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors) and Key Geographical Regions (North America, Europe and Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering. The viral sensitizers market, a notable segment of the viral manufacturing consumables market, is anticipated to grow at a compounded annual growth rate (CAGR) of 14% during the forecast period 2023-2035. This report features an extensive study of the current market landscape, market size and future opportunities associated with this industry, for the given forecast period. The market research report highlights the efforts of several stakeholders engaged in this rapidly evolving segment of the viral manufacturing industry. Key takeaways of the viral sensitizers market report are briefly discussed below. The key objective of this market report is to provide a detailed market forecast analysis in order to estimate th
Show less
Read more
Impact Snapshot
Event Time:
ARWR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARWR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARWR alerts
High impacting Arrowhead Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ARWR
News
- Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty PharmaBusiness Wire
- Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences [Yahoo! Finance]Yahoo! Finance
- Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 ConferencesBusiness Wire
- Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D WebinarsBusiness Wire
- Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter ResultsBusiness Wire
ARWR
Earnings
- 8/7/23 - Miss
ARWR
Sec Filings
- 5/2/24 - Form 144
- 4/10/24 - Form SC
- 4/3/24 - Form 4
- ARWR's page on the SEC website